Attorney Casey Leaver to Detail Cannabis Packaging Pitfalls at MJBizCon
A single label rarely satisfies every jurisdiction, and attorney Casey Leaver plans to walk operators through the compliance mistakes exposing them and retailers to risk.

Glass jars filled with cannabis buds artistically arranged on a shelf with playful labels.
Leaver's core message: one label doesn't travel
MJBizDaily reported that attorney Casey Leaver will break down packaging errors and how to stay fully compliant, with the central argument that a single label rarely works in every market.
The session is slated for MJBizCon, per the MJBizDaily preview published Nov. 12, 2026. The preview doesn't list the specific errors Leaver will cover, so the details remain hers to deliver.
The premise, though, is hard to dispute. Packaging is where compliance becomes physical.
Why a multistate operator can't copy and paste a package
American cannabis packaging is a patchwork of state rules, and a design approved in one program can be noncompliant in the next.
States differ on universal symbols, warning text, serving-size limits, child-resistant standards, opacity requirements and what imagery counts as appealing to minors. An operator running one master design is effectively betting that every regulator reads the rules the same way. They don't.
California's Department of Cannabis Control and Ohio's Division of Cannabis Control each enforce their own packaging and labeling regimes. A package built to satisfy one can miss a required statement or symbol in the other. The fix is rarely cosmetic. Label changes can force reprints, relabeling of finished inventory and, in the worst case, product pulled from shelves.
The risk runs downstream to retailers
Retailers carry exposure for what sits on their shelves, which is why packaging mistakes are a shared problem rather than a producer-only one.
A dispensary that stocks a noncompliant product can face its own enforcement action, depending on the jurisdiction. That pushes retailers to scrutinize supplier packaging, and it gives compliance-minded brands a commercial edge. Buyers increasingly ask for documentation, not just samples.
The MJBizDaily preview frames the topic around both operators and retailers, and that framing matters. Liability doesn't stop at the licensed producer.
The international comparison operators keep ignoring
Outside the U.S., packaging rules are often stricter and more centralized, which makes the American patchwork look permissive by comparison.
Health Canada sets a single national standard for plain packaging, standardized cannabis symbols and mandatory health warnings across the whole country. A Canadian licensed producer designs once, to one rulebook, and the rules are famously restrictive about branding. Germany's BfArM, which oversees medical cannabis supply, operates inside the EU's pharmaceutical labeling logic, where packaging is tied to product authorization and import documentation rather than lifestyle branding.
Neither model resembles a U.S. state program. For operators eyeing export markets, from Canada to Germany to the Czech Republic, the lesson is blunt: a domestic label is a starting point, not a finished product. And the International Narcotics Control Board's treaty framework adds another layer for anything crossing borders.
The practical takeaway from Leaver's premise is that packaging compliance should be treated as a per-market engineering problem, with each jurisdiction's rules mapped before artwork is finalized.
What operators should take from this
Treat packaging as a regulated product component, with legal review built into design rather than bolted on after printing.
The costliest mistakes tend to surface late, after labels are printed and inventory is packed. Catching a missing warning or a noncompliant graphic at the artwork stage is cheap. Catching it at a regulator inspection isn't.
Operators weighing expansion into new states, or into regulated markets like Canada and Germany, should budget for market-specific packaging runs and the legal review that goes with them. A relabeling project or a recall costs far more than a compliance check upfront, and that math is hard to argue with.
For broader context on how these rules fit together, see the CannIntel topic hub on cannabis packaging and labeling compliance.
The next signal: whatever specifics Leaver shares at MJBizCon, and whether regulators in states like California and Ohio tighten packaging enforcement as multistate brands scale.
Frequently asked questions
Who is Casey Leaver and what will she present at MJBizCon?
Casey Leaver is an attorney who, according to MJBizDaily, will break down common cannabis packaging mistakes and explain how operators can stay fully compliant. The preview emphasizes that one label rarely fits every market.
Why can't cannabis companies use one label in every state?
U.S. states set their own rules on warning text, universal symbols, child-resistant packaging, serving sizes and marketing imagery. A label compliant in one program can miss required elements or violate restrictions in another, forcing reprints or recalls.
Are retailers liable for noncompliant cannabis packaging?
Depending on the jurisdiction, dispensaries can face their own enforcement action for stocking noncompliant products. That is why retailers increasingly demand compliance documentation from suppliers rather than relying on producers alone.
How do international cannabis packaging rules compare to U.S. rules?
Health Canada applies one national plain-packaging and warning standard, while Germany's BfArM oversees medical cannabis within EU pharmaceutical labeling logic. Both are more centralized and restrictive than the U.S. state-by-state patchwork.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Bedrocan Restart Bid Could Revive Company, Report Says
A restart bid for Bedrocan, per Business of Cannabis, may bring the pioneering medical cannabis producer back. The signal is thin, and the open questions are legal and tax-driven.

Israel Still Alone in Acting on Canadian Cannabis Dumping Claims
Israel remains the only country to take formal action over below-cost export allegations against Canadian licensed producers, putting export pricing and cost records under scrutiny.

Israel Still Alone in Acting on Canadian Cannabis Dumping Claims
MJBizDaily reports Israel remains the only country to take formal action over allegations that Canadian licensed producers sell cannabis abroad below cost.
More from the newsroom

Missouri Law Tightening Marijuana, Hemp Rules Takes Effect
A new Missouri statute reshaping the state's marijuana and hemp regulatory framework is now in force, though the signal supplies few operational specifics.

Georgia Marine veteran credits medical cannabis for return to skateboarding
A CBS News profile puts a face on Georgia's narrow low-THC program, where veterans can qualify for oil but still lack a legal in-state retail supply chain.

IOL: Positive dagga test doesn't prove impairment at work
A South African workplace-testing report says a positive cannabis result shows past use, not on-the-job impairment, a gap that matters for employers acting on it.